Please develop a SOAP note for a 58‑year‑old male with hypertension, hyperlipidemia, and a 20‑pack‑year smoking history who had an exercise stress test showing significant ST‑segment depression in the inferior leads consistent with inducible myocardial ischemia, and explain the meaning of this cardiac diagnostic and its impact on his treatment plan.

SOAP Note: 58-Year-Old Male with Positive Exercise Stress Test

Subjective

• Chief Concern: Abnormal exercise stress test showing ST-segment depression
• 58-year-old male with hypertension, hyperlipidemia, and 20 pack-year smoking history 1
• No reported chest pain, dyspnea, or other cardiac symptoms at rest 1
• Currently on antihypertensive and lipid-lowering medications (specify agents and doses)
• Exercise tolerance and functional capacity prior to testing (document baseline activity level) 1

Objective

• Vital Signs: Blood pressure, heart rate, weight, BMI 2
• Physical Examination: Cardiac auscultation for gallops or murmurs, lung examination, peripheral pulses 1
• Exercise Stress Test Results:
  • Significant ST-segment depression in inferior leads (specify magnitude in mm and timing) 1
  • Workload achieved, peak heart rate, rate-pressure product 1
  • Symptoms during exercise (chest pain, dyspnea, lightheadedness) 1
  • Blood pressure response (normal increase is ~51 mmHg systolic; abnormal if <30 mmHg or >80 mmHg) 2
  • Heart rate recovery (abnormal if delayed, associated with increased mortality) 1
  • Time of ST-segment depression onset and duration into recovery 1

Assessment

This patient has high-risk features for significant coronary artery disease requiring urgent coronary angiography. The presence of exercise-induced ST-segment depression in the inferior leads indicates inducible myocardial ischemia, placing him at intermediate-to-high risk for major adverse cardiac events 1.

Risk Stratification

• High-risk features (≥3% annual death or MI) include: ≥2 mm ST-segment depression at low workload or persisting into recovery, exercise-induced ST-segment elevation, or exercise-induced ventricular arrhythmias 1
• Intermediate-risk features (1-3% annual death or MI) include: ≥1 mm ST-segment depression occurring with exertional symptoms 1
• The severity of coronary artery disease correlates with the degree of ST-segment depression, time of appearance (earlier onset = worse prognosis), duration into recovery, and number of leads involved 1
• In hypertensive patients, ST-segment depression can occur even without significant epicardial coronary stenosis due to left ventricular hypertrophy and microvascular disease, though this is less specific than wall motion abnormalities 3

Diagnostic Interpretation

• ST-segment depression ≥1 mm (0.10 mV) for ≥80 ms is the standard criterion for exercise-induced myocardial ischemia 1
• Horizontal or downsloping ST-segment depression is more specific than upsloping depression 1
• Inferior lead involvement suggests right coronary artery or left circumflex territory ischemia 1
• In hypertensive patients without known CAD, 15-23% demonstrate ST-segment depression on exercise testing, with most episodes being asymptomatic 4, 5

Additional Considerations

• Hypertension independently increases cardiovascular disease risk 5.68-fold in patients with dyslipidemia 6
• Smoking (20 pack-years) further compounds risk, with each pack-year increasing odds of cardiovascular events 6
• Silent ischemia is highly prevalent (79-94%) in hypertensive patients, making stress testing critical for risk assessment 4, 7

Plan

Immediate Management

Proceed directly to coronary angiography to define coronary anatomy and guide revascularization decisions. Exercise-induced ST-segment depression with this risk factor profile warrants invasive evaluation to identify obstructive coronary artery disease amenable to percutaneous coronary intervention or coronary artery bypass grafting 1.

• If angiography reveals multivessel disease (≥70% stenosis) or left main stenosis (≥50%), this confirms high-risk anatomy requiring revascularization 1
• If angiography shows single-vessel disease with ≥70% stenosis, this confirms intermediate-risk anatomy that may benefit from revascularization based on ischemic burden 1
• If angiography reveals no significant stenosis (<50%), the ST-segment depression likely reflects left ventricular hypertrophy with microvascular dysfunction, requiring aggressive medical optimization 3

Medical Optimization (Initiated Immediately)

Intensify antianginal and risk-reduction therapy regardless of angiography timing:

• Beta-blocker therapy: Initiate or uptitrate (e.g., metoprolol, carvedilol, or betaxolol 10-20 mg daily) to reduce heart rate, blood pressure, and myocardial oxygen demand—this reduces ischemic episodes by 76-84% in hypertensive patients 8, 7
• Aspirin 81 mg daily for antiplatelet effect 1
• High-intensity statin therapy (atorvastatin 40-80 mg or rosuvastatin 20-40 mg) targeting LDL-C <70 mg/dL, ideally <55 mg/dL 9
• ACE inhibitor or ARB for blood pressure control targeting <130/80 mmHg and cardioprotection 9
• Sublingual nitroglycerin for symptomatic relief if angina develops 1

Risk Factor Modification

• Smoking cessation: Mandatory—refer to smoking cessation program, prescribe varenicline or bupropion, consider nicotine replacement 6
• Blood pressure control: Target <130/80 mmHg with combination therapy if needed 9
• Lipid management: Triglycerides are an independent predictor of cardiovascular disease in dyslipidemia; consider adding icosapent ethyl if TG >150 mg/dL despite statin 6
• Lifestyle modification: Mediterranean diet, 150 minutes/week moderate-intensity exercise (once cleared), weight loss if BMI >25 1

Follow-Up and Monitoring

• Cardiology consultation within 1 week for angiography scheduling and management coordination 1
• Repeat stress imaging (stress echocardiography or nuclear perfusion) if angiography is delayed or if symptoms change, to quantify ischemic burden and guide revascularization decisions 1, 3
• Echocardiography to assess left ventricular ejection fraction, wall motion abnormalities, and left ventricular hypertrophy (LVEF <35% or severe LV dysfunction = high risk) 1
• 24-hour ambulatory blood pressure monitoring if office readings are inconsistent or to assess nocturnal hypertension 4

Common Pitfalls to Avoid

• Do not dismiss ST-segment depression as "false positive" in hypertensive patients—while microvascular disease is common, obstructive CAD must be excluded given the high mortality risk 3, 4
• Do not delay angiography in high-risk patients—early appearance of ST-segment depression, prolonged recovery, or multiple leads involved mandate urgent invasive evaluation 1
• Do not rely solely on symptoms—most ischemic episodes in hypertensive patients are silent, and symptom absence does not exclude severe disease 4, 7
• Avoid exercise-induced hypotension—this is a high-risk feature associated with poor prognosis and should prompt emergent consideration of significant cardiac disease 1

Goals of Treatment

• Reduce premature cardiovascular death and prevent myocardial infarction 1
• Eliminate or nearly eliminate ischemic symptoms 1
• Maintain or restore satisfactory functional capacity and quality of life 1
• Prevent heart failure and other complications of stable ischemic heart disease 1